Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on prescription drug imports.

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell ...

This proves that Eli Lilly's obesity drug Zepbound, as a GLP-1/GIP agonist ... will be able to take advantage of a 33.50% discount price of $399 per year. Analyst’s Disclosure: I/we have ...

Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...

From late 2020 to the summer of 2024, Eli Lilly ... in share price, however, investor sentiment for the next line of drugs front ran the stock price. For example, in 2016 Lilly was trading ...

Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on ...